<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3413892/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413892/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Cancer"><meta name="citation_title" content="Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity"><meta name="citation_authors" content="Peter H. O’Donnell, Amy L. Stark, Eric R. Gamazon, Heather E. Wheeler, Bridget E. McIlwee, Lidija Gorsic, Hae Kyung Im, R. Stephanie Huang, Nancy J. Cox, M. Eileen Dolan"><meta name="citation_date" content="15 August 2012"><meta name="citation_issue" content="16"><meta name="citation_volume" content="118"><meta name="citation_firstpage" content="4063"><meta name="citation_doi" content="10.1002/cncr.26737"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3413892/?report=abstract"><meta name="citation_pmid" content="22864933"><meta name="DC.Title" content="Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Peter H. O’Donnell"><meta name="DC.Contributor" content="Amy L. Stark"><meta name="DC.Contributor" content="Eric R. Gamazon"><meta name="DC.Contributor" content="Heather E. Wheeler"><meta name="DC.Contributor" content="Bridget E. McIlwee"><meta name="DC.Contributor" content="Lidija Gorsic"><meta name="DC.Contributor" content="Hae Kyung Im"><meta name="DC.Contributor" content="R. Stephanie Huang"><meta name="DC.Contributor" content="Nancy J. Cox"><meta name="DC.Contributor" content="M. Eileen Dolan"><meta name="DC.Date" content="2012 Aug 15"><meta name="DC.Identifier" content="10.1002/cncr.26737"><meta name="DC.Language" content="en"><meta property="og:title" content="Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity"><meta property="og:type" content="article"><meta property="og:description" content="Capecitabine, an oral 5-fluorouracil (5-FU) prodrug, is widely used in the treatment of breast, colorectal, and gastric cancers. To guide selection of patients potentially at greatest benefit of experiencing antitumor efficacy, or, alternatively, of developing ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413892/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3413892/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3413892/pdf/nihms339178.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE890370DD54BB110000000000070003.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413892%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3413892</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Cancer</a></span>. Author manuscript; available in PMC 2013 Aug 15.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22864933" target="pmc_ext" ref="reftype=publisher&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Cancer. 2012 Aug 15; 118(16): 4063–4073. </span></a></div><span class="fm-vol-iss-date">Published online 2012 Jan 3. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1002%2Fcncr.26737" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/cncr.26737</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3413892</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS339178</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22864933">22864933</a></div></div></div></div><h1 class="content-title">Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=O%26%23x02019%3BDonnell%20PH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598786557664" co-class="co-affbox">Peter H. O’Donnell</a>, M.D.,<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>*</sup> <a href="/pubmed/?term=Stark%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598791922720" co-class="co-affbox">Amy L. Stark</a>, Ph.D.,<sup>4,</sup><sup>*</sup> <a href="/pubmed/?term=Gamazon%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598784906816" co-class="co-affbox">Eric R. Gamazon</a>, M.S.,<sup>4</sup> <a href="/pubmed/?term=Wheeler%20HE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598782796080" co-class="co-affbox">Heather E. Wheeler</a>, Ph.D.,<sup>1</sup> <a href="/pubmed/?term=McIlwee%20BE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598784041072" co-class="co-affbox">Bridget E. McIlwee</a>, B.S.,<sup>1</sup> <a href="/pubmed/?term=Gorsic%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598784038592" co-class="co-affbox">Lidija Gorsic</a>, B.S.,<sup>1</sup> <a href="/pubmed/?term=Im%20HK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598780941568" co-class="co-affbox">Hae Kyung Im</a>, Ph.D.,<sup>5</sup> <a href="/pubmed/?term=Huang%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598783413008" co-class="co-affbox">R. Stephanie Huang</a>, Ph.D.,<sup>1,</sup><sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=Cox%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598781094048" co-class="co-affbox">Nancy J. Cox</a>, Ph.D.,<sup>1,</sup><sup>3</sup> and  <a href="/pubmed/?term=Dolan%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933" class="affpopup" co-rid="_co_idm140598792022944" co-class="co-affbox">M. Eileen Dolan</a>, Ph.D.<sup>1,</sup><sup>2,</sup><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140598786557664"><h3 class="no_margin">Peter H. O’Donnell</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><p><sup>2</sup>Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA</p><p><sup>3</sup>Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=O%26%23x02019%3BDonnell%20PH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Peter H. O’Donnell</a></div></div><div id="_co_idm140598791922720"><h3 class="no_margin">Amy L. Stark</h3><p><sup>4</sup>Department of Human Genetics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Stark%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Amy L. Stark</a></div></div><div id="_co_idm140598784906816"><h3 class="no_margin">Eric R. Gamazon</h3><p><sup>4</sup>Department of Human Genetics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Gamazon%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Eric R. Gamazon</a></div></div><div id="_co_idm140598782796080"><h3 class="no_margin">Heather E. Wheeler</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Wheeler%20HE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Heather E. Wheeler</a></div></div><div id="_co_idm140598784041072"><h3 class="no_margin">Bridget E. McIlwee</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=McIlwee%20BE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Bridget E. McIlwee</a></div></div><div id="_co_idm140598784038592"><h3 class="no_margin">Lidija Gorsic</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Gorsic%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Lidija Gorsic</a></div></div><div id="_co_idm140598780941568"><h3 class="no_margin">Hae Kyung Im</h3><p><sup>5</sup>Department of Health Studies, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Im%20HK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Hae Kyung Im</a></div></div><div id="_co_idm140598783413008"><h3 class="no_margin">R. Stephanie Huang</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><p><sup>2</sup>Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA</p><p><sup>3</sup>Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Huang%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">R. Stephanie Huang</a></div></div><div id="_co_idm140598781094048"><h3 class="no_margin">Nancy J. Cox</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><p><sup>3</sup>Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Cox%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">Nancy J. Cox</a></div></div><div id="_co_idm140598792022944"><h3 class="no_margin">M. Eileen Dolan</h3><p><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</p><p><sup>2</sup>Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA</p><p><sup>3</sup>Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Dolan%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22864933">M. Eileen Dolan</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140598790358416_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140598790358416_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140598790358416_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Medicine, The University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Human Genetics, The University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Health Studies, The University of Chicago, Chicago, IL, USA</div><div id="FN1">Address for correspondence/reprints: M. Eileen Dolan, Ph.D., 900 E 57<sup>th</sup> Street, KCBD 7100, The University of Chicago, Chicago, IL 60637. Phone: 773-702-4441, Fax: 773-702-9268, <a href="mailto:dev@null" data-email="ude.ogacihcu.dsb.enicidem@nalode" class="oemail">ude.ogacihcu.dsb.enicidem@nalode</a></div><div id="FN2"><sup>*</sup>equal contributors</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140598790358416_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22864933" target="pmc_ext" ref="reftype=publisher&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cancer</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3413892/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm140598789727520" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140598789727520title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">BACKGROUND</h3><p id="P1" class="p p-first-last">Capecitabine, an oral 5-fluorouracil (5-FU) prodrug, is widely used in the treatment of breast, colorectal, and gastric cancers. To guide selection of patients potentially at greatest benefit of experiencing antitumor efficacy, or, alternatively, of developing toxicities, identifying genomic predictors of capecitabine sensitivity could permit its more informed use.</p></div><div id="S2" class="sec"><h3 id="S2title">METHODS</h3><p id="P2" class="p p-first-last">Our objective was to perform capecitabine sensitivity genome-wide association studies (GWAS) using 503 well-genotyped human cell lines from individuals representing multiple different world populations. Meta-analysis including all ethnic populations then enabled identification of novel germline determinants (SNPs) of capecitabine susceptibility.</p></div><div id="S3" class="sec"><h3 id="S3title">RESULTS</h3><p id="P3" class="p p-first-last">First, intra-population GWAS of Caucasian individuals identified rs4702484 (within <em>ADCY2</em>) at a level reaching genome-wide significance (P=5.2×10<sup>−8</sup>). This SNP is located upstream of <em>MTRR</em> (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), a gene whose enzyme is known to be involved in the methionine-folate biosynthesis and metabolism pathway that is the primary target of 5-FU-related compounds, although we were unable to find a direct relationship between rs4702484 and <em>MTRR</em> expression in a tested subset of cells. In the meta-analysis, 4 SNPs comprised the top hits including again rs4702484 and three additional SNPs (rs8101143, rs576523, rs361433) that approached genome-wide significance (P values 1.9×10<sup>−7</sup>—8.8×10<sup>−7</sup>). Meta-analysis also identified one missense variant (rs11722476; Ser to Asn) within <em>SMARCAD1,</em> a novel gene for association with capecitabine/5-FU susceptibility.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">CONCLUSIONS</h3><p id="P4" class="p p-first-last">Toward the goal of individualizing cancer chemotherapy, our study identified novel SNPs and genes associated with capecitabine sensitivity that are potentially informative and testable in any patient, regardless of ethnicity.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">capecitabine, susceptibility, pharmacogenomics, genome-wide, meta-analysis</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">Variation in drug response is both clinically expected and relatively poorly predicted<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297399">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297429">2</a></sup>. Chemotherapy, in particular, is plagued by highly variable response rates as well as significant toxicity<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297419">1</a></sup>. Capecitabine is a chemotherapeutic agent widely used in the treatment of breast, colorectal, and gastric cancers<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_308115768">3</a></sup>. It is an oral, 5-fluorouracil (5-FU) prodrug designed to have limited toxicity due to preferential activation in tumor cells<sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297436">4</a></sup>. However, toxicities can result including, in particular, gastrointestinal toxicity and hand-foot syndrome<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297412">5</a></sup>. Identifying genetic predictors of capecitabine susceptibility could permit more informed use of this therapy by guiding selection of patients potentially most likely to experience antitumor efficacy, or alternatively to recognize patients who might be at particular risk of developing toxicities. Notably, capecitabine is particularly well suited for pharmacogenomic study because, compared to other oncologic drugs, it is often used as single-agent therapy<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297434">6</a>,<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297394">7</a></sup>.</p><p id="P6">Toward discovery of genetic variants governing chemotherapeutic susceptibility in patients, we developed a human cell-based model<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297425">8</a></sup>. The model utilizes lymphoblastoid cell lines (LCLs) collected from individuals across the globe as part of the International HapMap project, with genotype information publicly available for each individual<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297432">9</a></sup>. Previous genome-wide discovery work has utilized populations of these cells for several pharmacologic agents including cytarabine<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297421">10</a></sup>, daunorubicin<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297402">11</a></sup>, etoposide<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297427">12</a></sup>, cisplatin, and carboplatin<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297407">13</a>–<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297389">15</a></sup>. LCLs offer a model for genome-wide discovery without the confounders of diet, co-medications, and comorbidities<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297396">16</a></sup>. Genetic variants discovered using this model have been validated in clinical settings<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297388">17</a></sup>.</p><p id="P7" class="p p-last">Pharmacoethnicity<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297403">18</a></sup>, the concept that different ethnic populations have different responses to the same drug, makes population-based studies particularly informative. Although genetics may not be the only factor contributing to different responses across different ethnic groups, it is likely an important component. While discovery of ethnic-specific polymorphisms is useful, the ultimate goal for clinical translation of pharmacogenomics remains the discovery of genetic polymorphisms (SNPs) that are informative and testable in any patient, regardless of ethnicity<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297428">1</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297416">13</a>, <a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297410">18</a></sup>. Therefore, to identify SNPs for testing in the clinical setting, our objective was to interrogate capecitabine susceptibility using genome-wide association in over 500 individuals’ samples and to perform cross-population meta-analysis to characterize genetic determinants of sensitivity in individuals representing diverse global backgrounds.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Phenotyping</h3><p id="P8" class="p p-first">HapMap cell lines from six different panels were purchased from Coriell Institute for Medical Research (<a href="http://www.coriell.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.coriell.org</a>) and used for susceptibility phenotyping: 84 unrelated Asian (ASN) individuals’ LCLs from HapMap Phase I (individuals from Tokyo, Japan, and Beijing, China); 84 LCLs representing Caucasian individuals from Utah, U.S. with northern/western European ancestry (CEU) in trio structure (two parents plus their child) from HapMap I (CEU1); 80 LCLs from CEU in trio structure from HapMap Phase III (CEU3); 87 LCLs from the Yoruba individuals of Ibadan, Nigeria (YRI) in trio structure from HapMap I (YRI1); 86 LCLs from YRI in trio structure from HapMap III (YRI3); and 82 LCLs from an African-American population from the Southwest U.S. (ASW) in trio structure. LCLs were cultured in RPMI 1640 media (Cellgro, Herndon, VA) containing 15% heat-inactivated fetal bovine serum (Hyclone, Logan, UT) and 20mM L-glutamine. Cell lines were diluted 3 times/week at a concentration of 300,000–350,000 cells/mL and maintained in a 37°C, 5% CO<sub>2</sub> humidified incubator.</p><p id="P9" class="p p-last">Using capecitabine in LCLs is hindered by the lack of expression of cytidine deaminase<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297438">19</a></sup> which is required for conversion of capecitabine to its active form. To circumvent this step in enzymatic activation, 5′-deoxy-5-fluorouridine (5′DFUR), a major metabolite of capecitabine, was used to evaluate capecitabine sensitivity using a short-term cellular growth inhibition assay<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297440">20</a></sup>. LCLs in the exponential growth phase with &gt;85% viability (Vi-Cell XR viability analyzer, Beckman Coulter, Fullerton, CA) were plated in triplicate at density=1×10<sup>5</sup> cells/mL in 96-well round-bottom plates (Corning, Corning, NY) 24 hours prior to drug treatment. Drug was added immediately after preparation of stock at the following concentrations: 2.5, 10, 20, and 40 μM and left on cells for 72 hours. AlamarBlue was added 24 hours before absorbance reading at wavelengths=570nm and 600nm (Synergy-HT multi-detection plate reader, BioTek, Winooski, VT). Percent survival was quantified relative to a control well without drug and, at each concentration, represents two separate experiments each performed in triplicate. Area under the survival curve (AUC), representing sensitivity to the drug, was calculated for each cell line using the trapezoidal rule and was log<sub>2</sub>-transformed for all data analysis. For comparisons between populations, AUC values were corrected for cellular growth rate<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297422">20</a>, <a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297441">21</a></sup> by subtracting each cell line’s AUC phenotype with the cellular growth rate multiplied by the linear regression coefficient for growth rate. For performing the genome-wide association studies (GWAS), uncorrected AUCs were utilized so that any growth rate-associated variants could also potentially be identified.</p></div><div id="S8" class="sec"><h3 id="S8title">Genotyping</h3><p id="P10" class="p p-first-last">Genotypes were downloaded from the HapMap Consortium release. Fewer genotypes were available for LCLs from Phase III HapMap (ASW, YRI3, CEU3) when compared to Phase I samples (for which &gt;2 million SNPs were available). To make these populations more comparable, imputation was performed for Phase III lines individually using BEAGLE<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297414">22</a></sup>. For CEU3 and YRI3, CEU1 and YRI1 (HapMap r22) respectively were used as reference. To measure accuracy of imputation at each SNP, R<sup>2</sup> was calculated as described following 100 imputations<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297418">22</a></sup>. Imputed genotypes with R<sup>2</sup>&gt;0.80, minor allele frequency (MAF)&gt;0.05, no Mendelian errors, and in Hardy-Weinberg equilibrium (P&gt;0.001) were carried through the rest of the analysis. For ASW, the same process was followed using both YRI1 and CEU1 as reference.</p></div><div id="S9" class="sec"><h3 id="S9title">GWAS Analyses</h3><p id="P11" class="p p-first">Each of the six HapMap panels was analyzed by a GWAS independently. Since GWA studies assume normality in the data, we first ensured this for each population. For five of the six panels, log<sub>2</sub>-transformed AUC phenotypes achieved normal distributions. Because log<sub>2</sub>-transformation in the ASW did not yield a normal distribution (Shapiro-Wilk test), the ASW population required rank-normalization to achieve normality. Rank-normalization was performed using the rntransform function in the R GenABEL package.</p><p id="P12">For CEU1, CEU3, YRI1, and YRI3, &gt;2 million SNPs (MAF&gt;5% within the panel, no Mendelian errors, and in Hardy Weinberg equilibrium [P&gt;0.001]) were tested for association using the quantitative trait disequilibrium test (QTDT)<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297426">23</a></sup>. In ASW, local ancestry at each SNP was estimated using HAPMIX<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297415">24</a></sup>. Phased genotypes from CEU1 and YRI1 were used as the ancestral populations to estimate ancestry. GWAS was performed using QTDT with local ancestry (a fractional predicted number of chromosomes) as covariate.</p><p id="P13" class="p p-last">A genomic control value<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297395">25</a></sup> was calculated for each GWAS. Correction for residual inflation of the test statistic was done for studies with λ&gt;1. Resulting P values (possibly adjusted) were carried forward to the meta-analysis.</p></div><div id="S10" class="sec sec-last"><h3 id="S10title">Meta-analysis</h3><p id="P14" class="p p-first-last">To identify SNPs associated with capecitabine-induced cytotoxicity, we conducted a meta-analysis to assimilate the results of the GWA studies from the individual populations. We used METAL<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297442">26</a></sup>, which combines P values across the studies for each SNP using a study-specific weight (sample size) and the direction of effect (β). At each SNP, the direction of effect and the P values from the individual studies were converted into signed <em>Z</em>-scores. <em>Z</em>-scores were combined with weights proportional to the square root of the sample size for each study.</p></div></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">Results</h2><div id="S12" class="sec sec-first"><h3 id="S12title">Phenotype Variation Across Ethnic Groups</h3><p id="P15" class="p p-first-last"><a href="/pmc/articles/PMC3413892/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a> shows the susceptibility phenotype results, grouped by ethnic population, for all 503 included cell lines upon exposure to the capecitabine metabolite 5′DFUR. Inter-population comparisons show that YRI were most sensitive to growth inhibitory effects of capecitabine, with a median AUC significantly lower than CEU (P=8.5×10<sup>−8</sup>) and ASN (P=6×10<sup>−3</sup>) but not significantly different from ASW. The CEU population was the most resistant. Because previous work has shown significant growth rate differences across HapMap populations<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297417">21</a></sup> and that growth rate is a significant confounder of pharmacologic endpoints including for 5′DFUR<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297437">20</a></sup>, the AUC measurement is corrected for growth rate to allow the most appropriate comparisons.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3413892/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598777088544" class="figure"><a href="/pmc/articles/PMC3413892/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3413892_nihms339178f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3413892/bin/nihms339178f1.jpg"></a></div><div id="largeobj_idm140598777088544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3413892/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Celluar sensitivity to capecitabine in 503 HapMap lymphoblastoid cell lines</strong><p id="__p4">The YRI population was the most sensitive to growth inhibitory effects of 5′DFUR (capecitabine) with a median AUC significantly lower than that of CEU (P=8.5×10<sup>−8</sup>) and ASN (P=6×10<sup>−3</sup>) but not significantly different from ASW.</p></div></div></div></div><div id="S13" class="sec"><h3 id="S13title">Individual Population GWAS Reveal Top SNP Finding in Caucasians</h3><p id="P16" class="p p-first">Since some inter-population differences in sensitivity were observed, we first conducted individual, intra-population GWA studies for each ethnic population so that any potentially important population-restricted SNPs might be identified. Such SNPs may in fact be important toward explaining inter-ethnic susceptibility differences<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297431">13</a>, <a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297391">27</a></sup> like those seen in <a href="/pmc/articles/PMC3413892/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>.</p><p id="P17">Manhattan plots showing GWAS results for each population are illustrated in <a href="/pmc/articles/PMC3413892/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a> (CEU) and <a href="/pmc/articles/PMC3413892/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a> (YRI, ASW, ASN). While there are interesting findings for each population, the most intriguing result was produced by the CEU GWAS. The top CEU signal—considerably stronger than any other signal in the entire CEU GWAS—identified rs4702484 at a level that approximated genome-wide significance (P=5.2×10<sup>−8</sup>). This SNP, located in an intronic region of <em>ADCY2</em> (adenylate cyclase), has a CEU MAF=12%. Additionally, as can be seen in the chromosomal plot of this region (<a href="/pmc/articles/PMC3413892/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>), rs4702484 is located just upstream of <em>MTRR</em> (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), a gene whose enzyme is known to be involved in the methionine-folate biosynthesis and metabolism pathway<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297439">28</a></sup>. 5-FU-related compounds have been previously shown to target other enzymes in this pathway<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297411">29</a></sup>, but a potential pharmacogenomic relationship with <em>MTRR</em> would, to our knowledge, be novel.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3413892/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598782232512" class="figure"><a href="/pmc/articles/PMC3413892/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3413892_nihms339178f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3413892/bin/nihms339178f2.jpg"></a></div><div id="largeobj_idm140598782232512" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3413892/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>GWAS in Caucasian individuals identified a novel variant, rs4702484, associated with capecitabine sensitivity at a level reaching genome-wide significance (P=5.2×10<sup>−8</sup>)</strong><p id="__p5">(A) Manhattan plot showing capecitabine susceptibility GWAS results in CEU. (B) Zoom-in view of chromosome 5 region around top CEU GWAS SNP, rs4702484. The location within <em>ADCY2</em> (adenylate cyclase) is shown, in addition to its close proximity (upstream) of <em>MTRR</em> (5-methyltetrahydrofolate-homocysteine methyltransferase reductase). r<sup>2</sup> patterns designate LD probabilities with other SNPs in the region.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3413892/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598770932160" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f3.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms339178f3.jpg" src="/pmc/articles/PMC3413892/bin/nihms339178f3.jpg"></div></a><div id="largeobj_idm140598770932160" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3413892/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC3413892/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Manhattan plots of GWAS results for capecitabine sensitivity in different populations</strong><p id="__p6">(A): YRI; (B): ASW; (C): ASN.</p></div></div></div><p id="P18" class="p p-last">Using whole-genome mRNA expression data that we previously generated in our CEU1 LCLs using Affymetrix Exon Array 1.0<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297397">19</a></sup>, we investigated in an exploratory manner whether there was a statistical correlation between rs4702484 and <em>MTRR</em> mRNA expression levels in 30 CEU LCL trios (90 samples) using QTDT software, however we were unable to find a direct relationship in this limited subset.</p></div><div id="S14" class="sec"><h3 id="S14title">Meta-Analysis Results of the Population-Based GWA Studies</h3><p id="P19" class="p p-first">A meta-analysis of the individual population data was next performed to identify the most significant SNPs incorporating all populations. <a href="/pmc/articles/PMC3413892/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a> shows the full meta-analysis results in a Manhattan plot. While none of the top SNP associations reached the traditional cutoff for GWA statistical significance<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297401">30</a></sup>, 4 SNPs approached this threshold (rs8101143, rs576523, rs4702484, rs361433; P values 1.9×10<sup>−7</sup>—8 8×10<sup>−7</sup>). An additional 23 top SNPs had P values &lt;10<sup>−5</sup> (<a href="/pmc/articles/PMC3413892/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). It is noteworthy that the previously identified top CEU SNP, rs4702484, remained highly significant (and ranked third overall) in the meta-analysis (meta P=6.4×10<sup>−7</sup>). This SNP did not have a MAF&gt;0.05 in the YRI or ASW populations; in ASN, P=0.34.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3413892/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598792088480" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f4.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms339178f4.jpg" src="/pmc/articles/PMC3413892/bin/nihms339178f4.jpg"></div></a><div id="largeobj_idm140598792088480" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3413892/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a target="object" href="/pmc/articles/PMC3413892/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Meta-anlaysis of individual LCLs from CEU, YRI, ASW and ASN populations</strong><p id="__p7">Manhattan plot showing meta-analysis results of capecitabine susceptibility GWA studies including all of the utilized combined world populations (n=503 individuals).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Top SNPs from the multi-population meta-analysis of genome-wide association findings for capecitabine susceptibility</strong><p id="__p11">While 503 individuals’ samples were tested overall for capecitabine susceptibility, the number of samples analyzed for each SNP (far right column) was less if the SNP was monomorphic or rare (MAF&lt;5%) in some ethnic groups, or, in infrequent cases, if HapMap or imputation genotypes were unavailable.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598783124560" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Chromosome</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Gene</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">SNP</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Location</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Meta-analysis P Value</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Overall Rank (by P value)</span></th><th rowspan="1" colspan="1" valign="bottom" align="center"><span class="underline">Number of Individual Samples Tested</span></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">1</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs576523</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">2.3×10<sup>−07</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">172</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>PDE4DIP</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs2863344</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">1.9×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">9</td><td rowspan="1" colspan="1" valign="top" align="center">156</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>SLC44A5</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs1249675</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">6.5×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">17</td><td rowspan="1" colspan="1" valign="top" align="center">491</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">2</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs4848143</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">9.3×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">27</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">329</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs6771019</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">2.1×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">83</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs9824150</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">6.6×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">18</td><td rowspan="1" colspan="1" valign="top" align="center">244</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">4</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs11941399</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">6</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">328</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"><em>SMARCAD1</em></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs3106136</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">intron</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">7.2×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">23</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">484</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"><em>SMARCAD1</em></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs183993</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">intron</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">8.3×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">25</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">502</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">5</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ADCY2</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs4702484</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">6.4×10<sup>−07</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">248</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">6</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs2524276</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">6.3×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">16</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">246</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"><em>LOC643281</em></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs12198063</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">intron</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">7.6×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">24</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">245</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs361433</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">8.8×10<sup>−07</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4</td><td rowspan="1" colspan="1" valign="top" align="center">251</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs2882834</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">5</td><td rowspan="1" colspan="1" valign="top" align="center">494</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs6971109</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">6.8×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">20</td><td rowspan="1" colspan="1" valign="top" align="center">503</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">10</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs705469</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">6.8×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">19</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">495</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"><em>SH2D4B</em></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs6586111</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">intron</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">7.1×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">21</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">487</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"><em>SH2D4B</em></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs7915642</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">intron</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">8.5×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">26</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">489</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center"></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs705471</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">7.2×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">22</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">493</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOX6</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs16932455</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">1.5×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">329</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOX6</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs12577378</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">1.8×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">330</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOX6</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs7947008</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">2.6×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center">336</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOX6</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs12576205</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">4.9×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">14</td><td rowspan="1" colspan="1" valign="top" align="center">257</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOX6</em></td><td rowspan="1" colspan="1" valign="top" align="center">rs16932445</td><td rowspan="1" colspan="1" valign="top" align="center">intron</td><td rowspan="1" colspan="1" valign="top" align="center">4.9×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">15</td><td rowspan="1" colspan="1" valign="top" align="center">257</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">13</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs6490525</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">3.9×10<sup>−06</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">13</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">246</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">18</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">rs9953852</td><td rowspan="1" colspan="1" valign="top" align="center">---</td><td rowspan="1" colspan="1" valign="top" align="center">3.1×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">12</td><td rowspan="1" colspan="1" valign="top" align="center">252</td></tr><tr><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">19</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">rs8101143</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">---</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">1.9×10<sup>−07</sup></td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">1</td><td style="background-color:#808080" rowspan="1" colspan="1" valign="top" align="center">474</td></tr></tbody></table></div><div id="largeobj_idm140598783124560" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3413892/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P20" class="p p-last">We undertook an analysis to determine the proportion of SNPs identified from each intra-population GWAS that remained strongly significant in the meta-analysis (<a href="/pmc/articles/PMC3413892/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5</span></a>). Using an arbitrary cutoff of significance of P&lt;10<sup>−4</sup>, the ASN-only GWAS identified 200 top SNPs, 14 (7%) of which remained significant in the across-population meta-analysis. For CEU, 161 SNPs were identified by CEU-only GWAS, of which 29 (18%) were also significant in the meta-analysis. For YRI the proportion was 12% (33 of 279 SNPs). For ASW, 1 SNP remained significant in the meta-analysis out of 147 that had been identified by ASW-only GWAS.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3413892/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598786105168" class="figure"><a href="/pmc/articles/PMC3413892/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3413892_nihms339178f5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3413892/bin/nihms339178f5.jpg"></a></div><div id="largeobj_idm140598786105168" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3413892/figure/F5/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Graphical depiction of the proportion of SNPs identified from each intra-population GWAS that remained strongly significant in the meta-analysis</strong><p id="__p8">For example, the ASN-only GWAS identified 200 top SNPs (the sum of 14 + 186), 14 (7%) of which remained significant in the meta-analysis. An arbitrary cutoff of significance of P&lt;10<sup>−4</sup> was used. None of the SNPs from an individual population that remained strongly significantly in the meta-analysis were the same in multiple populations.</p></div></div></div></div><div id="S15" class="sec"><h3 id="S15title">Top Meta-Analysis SNPs Considering Directionality in All Populations</h3><p id="P21" class="p p-first">For analysis of the top meta-analysis SNPs having potential importance, we more closely interrogated all SNPs having P&lt;10<sup>−4</sup>, consistent with many of our previous cell-based analyses<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297408">8</a>, <a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297433">11</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297424">13</a>, <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297413">31</a></sup>. In the meta-analysis, 321 SNPs met this threshold. Upon inspection, it became apparent that these SNPs generally fell into one of three categories: 1) Directional agreement across all populations regarding the demonstrated association independent of significance of the association; 2) The meta-analysis P value was entirely driven by the association within a single population; 3) The direction of the genotype-phenotype association for the SNP was opposite for one or more of the ethnic populations.</p><p id="P22">One-third of the top SNPs (108 of 321 SNPs) fit the description of consistent genotype-phenotype association direction across all six individually evaluated populations (ASN, CEU1, CEU3, ASW, YRI1, YRI3). A representative example of this is shown for rs8101143 (P=1.9×10<sup>−7</sup>; top-ranked in the meta-analysis; <a href="/pmc/articles/PMC3413892/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6A</span></a>). This SNP was not identified by any of our single population GWAS since the strength of the association was low in any single ethnic population (P&gt;10<sup>−4</sup>), but strong when considering multiple populations in the meta-analysis, apparently as a result of reproducible, consistent directional effects in all of the included populations. Many additional SNPs (193 SNPs) also fell into this general category, in that the direction of the genotype-phenotype association was consistent across all ethnically distinct individual populations in which the variant was common (MAF&gt;5%) and present (not monomorphic). It is acknowledged that the meta-analysis methodology itself is designed to favor identification of “consistent-direction” SNPs among the top signals.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC3413892/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598790185120" class="figure"><a href="/pmc/articles/PMC3413892/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3413892_nihms339178f6.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3413892/bin/nihms339178f6.jpg"></a></div><div id="largeobj_idm140598790185120" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3413892/figure/F6/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Examples of SNPs identified in the meta-analysis</strong><p id="__p9">(A) SNP rs8101143 (P=1.9×10<sup>−7</sup>; ranked #1 in the meta-analysis) illustrates genotype-phenotype associations in the same direction across all six individually evaluated populations; (B) SNP rs576523, which is only polymorphic in the YRI population and, interestingly, was still the second most significant SNP in the overall meta-analysis (P=2.3×10<sup>−7</sup>) illustrates a SNP with a strong signal in the meta-analysis despite having a genotype-phenotype association only present in one population because the variant was monomorphic in all other populations; (C) SNP rs6971109 illustrates a top hit in the meta-analysis despite the fact that the consensus direction of the genotype-phenotype association for the SNP was opposite in one or more of the ethnic populations. The circular symbol indicates that the directionality of the association in that population was opposite that of the other populations (which are all similarly denoted with diamonds). The dashed vertical line in all panels identifies a P value of 0.05.</p></div></div></div><p id="P23">Another category was genotype-phenotype associations present only in one ethnically-restricted population because the variant was monomorphic or rare in all other populations. An example is shown for SNP rs576523 (<a href="/pmc/articles/PMC3413892/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6B</span></a>). rs576523 is only polymorphic in the YRI population and, interestingly, is the second-most significant SNP in the meta-analysis (P=2.3×10<sup>−7</sup>). In fact, three of the top 10 SNPs in <a href="/pmc/articles/PMC3413892/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> are considered polymorphic only in one population (rs576523 in YRI, rs2863344 in CEU, and rs6771019 in YRI). These results include a number of the “surviving” SNPs depicted in <a href="/pmc/articles/PMC3413892/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5</span></a>, and they likely represent some of the strongest findings given the strengths of the associations despite the fact that they are population-restricted.</p><p id="P24" class="p p-last">The third group includes SNPs in which the consensus direction of the genotype-phenotype association for the SNP was opposite for one or more of the ethnic populations, yet the strength of the association in the consensus direction was robust enough to achieve a meta-analysis P value reaching top significance (e.g., an association was positive for CEU, YRI, and ASW, but opposite for ASN, yet meta-analysis P value achieved &lt;10<sup>−4</sup>). An example of this is shown in <a href="/pmc/articles/PMC3413892/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6C</span></a>, for SNP rs6971109. Such SNPs might have relevance for general testing in most individuals with the knowledge that in a single ethnic population, the association might not be relevant. Only 20 of the top 321 SNPs fit this group, and in none of these 20 was the opposite direction-outlier population’s association statistically significant.</p></div><div id="S16" class="sec"><h3 id="S16title">Potential Functional Role of Top Meta-Analysis SNPs</h3><p id="P25" class="p p-first">Of the 321 top SNPs with P&lt;10<sup>−4</sup>, most (162 SNPs) are located in uncharacterized regions of the genome (i.e., not annotated to any known gene based on location), a finding that has been consistent in our previous studies using an unbiased genome-wide approach to chemotherapy susceptibility pharmacogenomics. Many others are located in introns (145 SNPs), although none are at known splice sites. Eight (8) SNPs are located either near known genes (rs263003 with <em>PARL</em>; rs3106134 with <em>SMARCAD1</em>; and rs972249 with <em>KRT40</em>) or in 3′ or 5′ untranslated (UTR) gene regions (rs7448390 and rs17101607 located in the 3′UTR of <em>YIPF5</em>; rs11635570 located in the 3′UTR of <em>MTFMT</em>; rs17039288 located in the 5′UTR of <em>MYT1L</em>; and rs3738414 located in the 5′UTR of <em>VTCN1</em>). One SNP (rs10907177) was a synonymous coding variant in a poorly-characterized gene region (<em>C1ORF159</em>).</p><p id="P26" class="p p-last">Perhaps most interesting was a missense SNP (rs11722476) within <em>SMARCAD1</em> (<a href="/pmc/articles/PMC3413892/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7A</span></a>). This SNP had a meta-analysis P value of 6.7×10<sup>−5</sup>. The G to A DNA change results in a serine to asparagine amino acid change in the SMARCAD1 (SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin) protein. The genotype-phenotype association for this SNP in the n=503 individuals is shown in <a href="/pmc/articles/PMC3413892/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7B</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC3413892/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598784956592" class="figure"><a href="/pmc/articles/PMC3413892/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3413892_nihms339178f7.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms339178f7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3413892/bin/nihms339178f7.jpg"></a></div><div id="largeobj_idm140598784956592" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3413892/figure/F7/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC3413892/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Meta-analysis of the cross-population GWAS identified rs11722476, a missense SNP within <em>SMARCAD1</em></strong><p id="__p10">(A) Zoom-in view of the genomic region on chromosome 4 around this SNP. The fact that a number of other signals within <em>SMARCAD1</em> were found is illustrated by the striking number of SNPs which were found at P values smaller than the arbitrary cutoff of P&lt;10<sup>−4</sup>; (B) Genotype-phenotype association for this SNP in the n=503 individuals.</p></div></div></div></div><div id="S17" class="sec sec-last"><h3 id="S17title">Effect of Thymidine Phosphorylase</h3><p id="P27" class="p p-first-last">Because inactive 5′DFUR requires activation to 5-FU via a final anabolizing enzyme, thymidine phosphorylase, and because thymidine phosphorylase levels can be affected by the relative expression of the thymidine phosphorylase gene (<em>TYMP</em>) in various human tissues<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297390">32</a></sup>, we lastly interrogated whether <em>TYMP</em> levels within LCLs correlated with 5′DFUR susceptibility in our study. Using our broad gene expression data in HapMap CEU1 and YRI1<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297405">19</a></sup>, we found a significant relationship between 5′DFUR AUC and <em>TYMP</em> expression in both CEU1 (P=1.5×10<sup>−4</sup>) and YRI1 (P=2.4×10<sup>−6</sup>). In both populations, the direction of the relationship indicated that higher <em>TYMP</em> expression correlated with lower AUC (β=−3.97 for CEU1 and -5.10 for YRI1), as might be hypothesized. However, the overall proportion of AUC variation explained by <em>TYMP</em> was only 0.15 for CEU1, and 0.22 for YRI1, supporting our above GWAS findings that there are other important sources of genetic variability in determining capecitabine (5′DFUR) sensitivity.</p></div></div><div id="S18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S18title">Discussion</h2><p id="P28" class="p p-first">We have herein described a novel human cell-based approach to identifying germline pharmacogenomic polymorphisms governing susceptibility to the widely-used chemotherapy drug capecitabine. By utilizing the inherent powerful genetic information encapsulated within the HapMap and a high-throughput cell-based chemotherapy susceptibility testing method, we were able to perform the largest known GWAS for capecitabine susceptibility pharmacogenomics, in over 500 individual samples. This comprehensive, “across-populations” chemotherapy study is the first of its kind—distinguished from previous cell-based pharmacogenomic approaches by the novel idea of conducting a meta-analysis across multiple ethnic populations. This exercise permitted a built-in method for statistical veracity testing of resulting SNPs, since the meta-analysis assimilated raw P values from individual population-based GWA studies and only the top SNPs showing strong association after consideration of all individual populations achieved robust meta-analysis P values. In this sense, many of our top SNPs from this meta-analysis might be therefore considered clinically testable for replication in the ethnically diverse human populations that are typically encountered in true clinical practice and in clinical research settings.</p><p id="P29">Our two most compelling genetic findings deserve particular discussion. SNP rs4702484 on chromosome 5 was identified among the top three SNPs in our meta-analysis in addition to being identified by our CEU intra-population GWAS (at a P value reaching genome-wide significance). While this SNP is intronic within <em>ADCY2</em>, close analysis of the genomic region around this SNP demonstrates that the SNP is quite proximal to the methionine-folate pathway gene <em>MTRR</em> (see <a href="/pmc/articles/PMC3413892/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). We therefore hypothesize that upstream regulation of <em>MTRR</em> (via polymorphism of its extended promoter region) may be likely, a mechanism which would fit with the purported site of activity of 5-FU related compounds like capecitabine within the folate metabolism/nucleotide biosynthesis pathway. While other capecitabine/5-FU pathway candidate genes (e.g., <em>TYMS, MTHFR, DPD</em>) have been well studied previously<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297392">33</a>–<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297400">35</a></sup>, we could find no prior positive reports implicating <em>MTRR</em> pharmacogenetic variation with 5-FU-related phenotypes (one recent study reported a negative finding with a different <em>MTRR</em> polymorphism<sup><a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_308115767">36</a></sup>). This increases the potential novelty of our finding. Perhaps most interestingly, if this relationship is indeed confirmed by ongoing functional studies of <em>MTRR</em>, this genetic relationship would be an example of a GWAS approach identifying a <em>de facto</em> “candidate gene” that has been largely previously ignored by classic candidate gene methods.</p><p id="P30">Separately, while a number of our other top meta-analysis SNPs are interesting for possible functional and clinical importance, the identification of SNP rs11722476 (a missense SNP within <em>SMARCAD1</em>) was especially intriguing. First, there were a noticeably large (and disproportionate) number of repetitive, strong signals within <em>SMARCAD1</em> among our top 321 meta-analysis SNPs (see <a href="/pmc/articles/PMC3413892/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7A</span></a>), and two signals within <em>SMARCAD1</em> (potentially in linkage disequilibrium [LD]) among the most significant (P&lt;10<sup>−5</sup>) overall SNPs (<a href="/pmc/articles/PMC3413892/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). These findings, along with the identification of the above missense SNP in this region, compositely suggest importance of this gene for capecitabine. SMARCAD1, a member of a helicase superfamily including proteins essential to genome replication, repair, and expression<sup><a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297409">37</a></sup>, has interestingly been previously mentioned (although only tangentially) in reports that would be consistent with a 5-FU-related importance. One study, using deletion mapping of chromosome 4q22–35, showed that <em>SMARCAD1</em> was frequently deleted in head and neck cancers<sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297435">38</a></sup>, which are often treated successfully by 5-FU. This might imply that <em>SMARCAD1</em> gene dosage effects could potentially underlie one mechanism of 5-FU susceptibility for these tumors. A second unrelated study found (via expression analysis) that SMARCAD1 has particularly high levels in endocrine tissues<sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297404">39</a></sup>. Breast tissue would be considered highly endocrine-responsive (estrogen/progesterone receptors) and therefore, while still speculative, this could begin to suggest a role for <em>SMARCAD1</em> polymorphism in explaining the sensitivity of breast cancers to capecitabine. Of course, such hypotheses would need to be confirmed by formal molecular studies, highlighting the fact that GWA studies are often excellent for permitting new hypothesis generation.</p><p id="P31">None of the typically-studied capecitabine/5-FU pathway candidate genes themselves (<em>TYMS, TYMP, MTHFR, DPYD,</em> among others) were identified among the top SNP signals in our study. This could be due, in part, to tissue-restricted down regulation of some of these genes in LCLs. However, it also illustrates the idea that a combined approach (genome-wide plus candidate gene methods) may ultimately yield the most comprehensive approach to drug susceptibility pharmacogenomics, perhaps especially in oncology. Additionally, there may be differences in the pharmacogenomics of capecitabine compared to 5-FU (just as there are differences in the toxicity profiles for these two drugs), and there has been relatively much less clinical investigation into the pharmacogenomics of capecitabine. One recent study implicated a role for <em>TYMS</em> in patients with colon cancer receiving a regimen containing capecitabine<sup><a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_308115766">40</a></sup>. A second prior study had also previously found the strongest evidence for <em>TYMS</em> among the typically-studied capecitabine candidate genes<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297423">41</a></sup>.</p><p id="P32">Our study has recognized limitations. While SNP rs4702484 did achieve genome-wide statistical significance in the CEU-only GWAS, none of the meta-analysis results achieved P values below the generally-accepted GWA cutoff of ~5×10<sup>−8 <a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297393">30</a></sup>. In this sense, the overall statistical power gained by combining six panels in the meta-analysis was probably less than we expected. This may be due to different underlying LD structures between the individual populations<sup><a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297420">42</a>,<a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297406">43</a></sup>. At the same time, it has been argued that additional factors in the comprehensive evaluation of GWAS findings need to be considered beyond just the P value threshold<sup><a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297430">44</a></sup>, and we would suggest that SNPs in our meta-analysis with P values of ~10<sup>−6</sup> or smaller—especially when the association directionality is consistent across all 6 individually-tested panels—have a higher likelihood of true importance. The fact that 4 SNPs indeed achieved P values of ~10<sup>−7</sup> (approaching traditional genome-wide significance) despite our sample size (~500 individuals) which would typically be considered too small for conducting a GWAS may emphasize the potential relevance of these findings. We believe it also simultaneously validates the utility of the meta-analysis approach. Secondly, the majority of the top identified SNPs are located in regions of the genome without obvious apparent functional explanation. This could reflect two possibilities: either this simply reflects the greater statistical probability of more commonly identifying variants in non-coding regions of the genome since those regions inherently comprise a vastly greater total percentage of the genome; or this signals the novelty and the advantage of GWAS studies like this one for interrogating chemotherapeutic pharmacogenomic traits, where an unbiased approach may be exactly what is desired, since candidate-gene or single-gene methods have often fallen short<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268297398">18</a></sup>. Thirdly, although the genetic information in this study is from human individuals in the HapMap project, and although meta-analysis approaches when conducted properly may obviate the need for additional replication in a separate population, the phenotypes were derived in a cell-line model and therefore the results require validation in clinical populations of patients taking capecitabine.</p><p id="P33">It should lastly be mentioned that while our cross-population method offers the advantage of identifying relatively common SNPs testable in all or most individuals regardless of ethnic background, we did find allelic heterogeneity among the top SNPs (and often one or more populations were monomorphic at a given identified locus) and, despite the value of a cross population meta-analysis, one of our strongest results was found via a single-population analysis, underscoring the value of individual population analyses as well.</p><p id="P34" class="p p-last">In summary, we conducted a large, cell-based meta-analysis of genome-wide association findings for capecitabine chemotherapy susceptibility across multiple divergent human populations. The resulting list of novel SNPs and related genes, along with SNPs in previously-identified capecitabine/5-FU pathway candidate genes, deserve study in clinical settings toward the goal of identifying underlying genetic factors influencing toxicity from, and perhaps response to, this commonly-used cancer agent. The ongoing multi-center clinical study examining comprehensive capecitabine toxicity pharmacogenomics (<a href="http://www.clinicaltrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.clinicaltrials.gov</a> study identifier <a id="__tag_562268119" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00977119" ref="reftype=extlink-clinical-trial&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00977119","term_id":"NCT00977119"}}</span>NCT00977119</a>) indeed plans to utilize these data for specifically that purpose.</p></div><div id="S19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Acknowledgments</h2><div class="sec"><p id="__p2">Supported by The University of Chicago Breast Cancer SPORE P50 CA125183 (MED), NIH/NIGMS UO1 GM61393 Pharmacogenomics of Anticancer Agents Research Group (MED; NJC), NIH/NCI F32 <a id="__tag_784011089" class="tag_hotlink" href="/nuccore/CA136123" ref="/nuccore/CA136123"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA136123","term_id":"35024806","term_text":"CA136123"}}</span>CA136123</a> (PHO), NIH TL1 RR25001 (ALS), and NIH/NIGMS K08 GM089941 (RSH).</p></div></div><div id="idm140598786807424" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140598786807424title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"></p><p id="__p3" class="p p-first-last">There are no relevant financial relationships to disclose for any authors.</p><p></p></div></div><div id="idm140598786806432" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140598786806432title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Efferth T, Volm M. Pharmacogenetics for individualized cancer chemotherapy. <span><span class="ref-journal">Pharmacology &amp; Therapeutics. </span>2005;<span class="ref-vol">107</span>:155–176.</span> [<a href="/pubmed/15890408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology+&amp;+Therapeutics&amp;title=Pharmacogenetics+for+individualized+cancer+chemotherapy&amp;author=T+Efferth&amp;author=M+Volm&amp;volume=107&amp;publication_year=2005&amp;pages=155-176&amp;pmid=15890408&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Evans WE, Relling MV. Pharmacogenomics: Translating functional genomics into rational therapeutics. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">286</span>:487–491.</span> [<a href="/pubmed/10521338" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Pharmacogenomics:+Translating+functional+genomics+into+rational+therapeutics&amp;author=WE+Evans&amp;author=MV+Relling&amp;volume=286&amp;publication_year=1999&amp;pages=487-491&amp;pmid=10521338&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Cassidy J, Saltz L, Twelves C, et al.  Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: A meta-analysis of individual data from 6171 patients. <span><span class="ref-journal">Ann Oncol. </span>2011</span> [<a href="/pubmed/21415237" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Efficacy+of+capecitabine+versus+5-fluorouracil+in+colorectal+and+gastric+cancers:+A+meta-analysis+of+individual+data+from+6171+patients&amp;author=J+Cassidy&amp;author=L+Saltz&amp;author=C+Twelves&amp;publication_year=2011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Walko CM, Lindley C. Capecitabine: A review. <span><span class="ref-journal">Clin Ther. </span>2005;<span class="ref-vol">27</span>:23–44.</span> [<a href="/pubmed/15763604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Ther&amp;title=Capecitabine:+A+review&amp;author=CM+Walko&amp;author=C+Lindley&amp;volume=27&amp;publication_year=2005&amp;pages=23-44&amp;pmid=15763604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Aprile G, Mazzer M, Moroso S, Puglisi F. Pharmacology and therapeutic efficacy of capecitabine: Focus on breast and colorectal cancer. <span><span class="ref-journal">Anticancer Drugs. </span>2009;<span class="ref-vol">20</span>:217–229.</span> [<a href="/pubmed/19247178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Drugs&amp;title=Pharmacology+and+therapeutic+efficacy+of+capecitabine:+Focus+on+breast+and+colorectal+cancer&amp;author=G+Aprile&amp;author=M+Mazzer&amp;author=S+Moroso&amp;author=F+Puglisi&amp;volume=20&amp;publication_year=2009&amp;pages=217-229&amp;pmid=19247178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Biganzoli L, Martin M, Twelves C. Moving forward with capecitabine: A glimpse of the future. <span><span class="ref-journal">Oncologist. </span>2002;<span class="ref-vol">7 </span>(Suppl 6):29–35.</span> [<a href="/pubmed/12454317" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=Moving+forward+with+capecitabine:+A+glimpse+of+the+future&amp;author=L+Biganzoli&amp;author=M+Martin&amp;author=C+Twelves&amp;volume=7+&amp;issue=Suppl+6&amp;publication_year=2002&amp;pages=29-35&amp;pmid=12454317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Clemons M, Joy AA, Abdulnabi R, et al.  Phase ii, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2010;<span class="ref-vol">124</span>:177–186.</span> [<a href="/pubmed/20814815" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Phase+ii,+double-blind,+randomized+trial+of+capecitabine+plus+enzastaurin+versus+capecitabine+plus+placebo+in+patients+with+metastatic+or+recurrent+breast+cancer+after+prior+anthracycline+and+taxane+therapy&amp;author=M+Clemons&amp;author=AA+Joy&amp;author=R+Abdulnabi&amp;volume=124&amp;publication_year=2010&amp;pages=177-186&amp;pmid=20814815&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Huang RS, Duan S, Bleibel WK, et al.  A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:9758–9763.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1887589/">PMC free article</a>]</span> [<a href="/pubmed/17537913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+genome-wide+approach+to+identify+genetic+variants+that+contribute+to+etoposide-induced+cytotoxicity&amp;author=RS+Huang&amp;author=S+Duan&amp;author=WK+Bleibel&amp;volume=104&amp;publication_year=2007&amp;pages=9758-9763&amp;pmid=17537913&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">A haplotype map of the human genome. <span><span class="ref-journal">Nature. </span>2005;<span class="ref-vol">437</span>:1299–1320.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1880871/">PMC free article</a>]</span> [<a href="/pubmed/16255080" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+haplotype+map+of+the+human+genome&amp;volume=437&amp;publication_year=2005&amp;pages=1299-1320&amp;pmid=16255080&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Hartford CM, Duan S, Delaney SM, et al.  Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. <span><span class="ref-journal">Blood. </span>2009;<span class="ref-vol">113</span>:2145–2153.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652364/">PMC free article</a>]</span> [<a href="/pubmed/19109566" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Population-specific+genetic+variants+important+in+susceptibility+to+cytarabine+arabinoside+cytotoxicity&amp;author=CM+Hartford&amp;author=S+Duan&amp;author=SM+Delaney&amp;volume=113&amp;publication_year=2009&amp;pages=2145-2153&amp;pmid=19109566&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Huang RS, Duan S, Kistner EO, et al.  Genetic variants contributing to daunorubicin-induced cytotoxicity. <span><span class="ref-journal">Cancer Res. </span>2008;<span class="ref-vol">68</span>:3161–3168.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2714371/">PMC free article</a>]</span> [<a href="/pubmed/18451141" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Genetic+variants+contributing+to+daunorubicin-induced+cytotoxicity&amp;author=RS+Huang&amp;author=S+Duan&amp;author=EO+Kistner&amp;volume=68&amp;publication_year=2008&amp;pages=3161-3168&amp;pmid=18451141&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Bleibel WK, Duan S, Huang RS, et al.  Identification of genomic regions contributing to etoposide-induced cytotoxicity. <span><span class="ref-journal">Hum Genet. </span>2009;<span class="ref-vol">125</span>:173–180.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2714550/">PMC free article</a>]</span> [<a href="/pubmed/19089452" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Genet&amp;title=Identification+of+genomic+regions+contributing+to+etoposide-induced+cytotoxicity&amp;author=WK+Bleibel&amp;author=S+Duan&amp;author=RS+Huang&amp;volume=125&amp;publication_year=2009&amp;pages=173-180&amp;pmid=19089452&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">O’Donnell PH, Gamazon E, Zhang W, et al.  Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2010;<span class="ref-vol">20</span>(5):327–337.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2908307/">PMC free article</a>]</span> [<a href="/pubmed/20393316" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Population+differences+in+platinum+toxicity+as+a+means+to+identify+novel+genetic+susceptibility+variants&amp;author=PH+O’Donnell&amp;author=E+Gamazon&amp;author=W+Zhang&amp;volume=20&amp;issue=5&amp;publication_year=2010&amp;pages=327-337&amp;pmid=20393316&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Shukla SJ, Duan S, Wu X, Badner JA, Kasza K, Dolan ME. Whole-genome approach implicates cd44 in cellular resistance to carboplatin. <span><span class="ref-journal">Human Genomics. </span>2009;<span class="ref-vol">3</span>:128–142.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2683878/">PMC free article</a>]</span> [<a href="/pubmed/19164090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Genomics&amp;title=Whole-genome+approach+implicates+cd44+in+cellular+resistance+to+carboplatin&amp;author=SJ+Shukla&amp;author=S+Duan&amp;author=X+Wu&amp;author=JA+Badner&amp;author=K+Kasza&amp;volume=3&amp;publication_year=2009&amp;pages=128-142&amp;pmid=19164090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from africans. <span><span class="ref-journal">Mol Cancer Ther. </span>2008;<span class="ref-vol">7</span>:3038–3046.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2743011/">PMC free article</a>]</span> [<a href="/pubmed/18765826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Genetic+variants+associated+with+carboplatin-induced+cytotoxicity+in+cell+lines+derived+from+africans&amp;author=RS+Huang&amp;author=S+Duan&amp;author=EO+Kistner&amp;author=CM+Hartford&amp;author=ME+Dolan&amp;volume=7&amp;publication_year=2008&amp;pages=3038-3046&amp;pmid=18765826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Welsh M, Mangravite L, Medina MW, et al.  Pharmacogenomic discovery using cell-based models. <span><span class="ref-journal">Pharmacol Rev. </span>2009;<span class="ref-vol">61</span>:413–429.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2802425/">PMC free article</a>]</span> [<a href="/pubmed/20038569" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;title=Pharmacogenomic+discovery+using+cell-based+models&amp;author=M+Welsh&amp;author=L+Mangravite&amp;author=MW+Medina&amp;volume=61&amp;publication_year=2009&amp;pages=413-429&amp;pmid=20038569&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Ziliak D, O’Donnell PH, Im HK, et al.  Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. <span><span class="ref-journal">Transl Res. </span>2011;<span class="ref-vol">157</span>:265–272.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3079878/">PMC free article</a>]</span> [<a href="/pubmed/21497773" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Transl+Res&amp;title=Germline+polymorphisms+discovered+via+a+cell-based,+genome-wide+approach+predict+platinum+response+in+head+and+neck+cancers&amp;author=D+Ziliak&amp;author=PH+O’Donnell&amp;author=HK+Im&amp;volume=157&amp;publication_year=2011&amp;pages=265-272&amp;pmid=21497773&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">O’Donnell PH, Dolan ME. Cancer pharmacoethnicity: Ethnic differences in susceptibility to the effects of chemotherapy. <span><span class="ref-journal">Clin Cancer Res. </span>2009;<span class="ref-vol">15</span>:4806–4814.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2774468/">PMC free article</a>]</span> [<a href="/pubmed/19622575" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Cancer+pharmacoethnicity:+Ethnic+differences+in+susceptibility+to+the+effects+of+chemotherapy&amp;author=PH+O’Donnell&amp;author=ME+Dolan&amp;volume=15&amp;publication_year=2009&amp;pages=4806-4814&amp;pmid=19622575&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Zhang W, Duan S, Kistner EO, et al.  Evaluation of genetic variation contributing to differences in gene expression between populations. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:631–640.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2427223/">PMC free article</a>]</span> [<a href="/pubmed/18313023" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Evaluation+of+genetic+variation+contributing+to+differences+in+gene+expression+between+populations&amp;author=W+Zhang&amp;author=S+Duan&amp;author=EO+Kistner&amp;volume=82&amp;publication_year=2008&amp;pages=631-640&amp;pmid=18313023&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Stark AL, Zhang W, Mi S, et al.  Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. <span><span class="ref-journal">Pharmacogenomics J. </span>2010;<span class="ref-vol">10</span>:505–512.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2975793/">PMC free article</a>]</span> [<a href="/pubmed/20142840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics+J&amp;title=Heritable+and+non-genetic+factors+as+variables+of+pharmacologic+phenotypes+in+lymphoblastoid+cell+lines&amp;author=AL+Stark&amp;author=W+Zhang&amp;author=S+Mi&amp;volume=10&amp;publication_year=2010&amp;pages=505-512&amp;pmid=20142840&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Stark AL, Zhang W, Zhou T, et al.  Population differences in the rate of proliferation of international hapmap cell lines. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:829–833.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2997375/">PMC free article</a>]</span> [<a href="/pubmed/21109222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Population+differences+in+the+rate+of+proliferation+of+international+hapmap+cell+lines&amp;author=AL+Stark&amp;author=W+Zhang&amp;author=T+Zhou&amp;volume=87&amp;publication_year=2010&amp;pages=829-833&amp;pmid=21109222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Browning BL, Browning SR. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">84</span>:210–223.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2668004/">PMC free article</a>]</span> [<a href="/pubmed/19200528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+unified+approach+to+genotype+imputation+and+haplotype-phase+inference+for+large+data+sets+of+trios+and+unrelated+individuals&amp;author=BL+Browning&amp;author=SR+Browning&amp;volume=84&amp;publication_year=2009&amp;pages=210-223&amp;pmid=19200528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Abecasis GR, Cookson WO, Cardon LR. Pedigree tests of transmission disequilibrium. <span><span class="ref-journal">Eur J Hum Genet. </span>2000;<span class="ref-vol">8</span>:545–551.</span> [<a href="/pubmed/10909856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Pedigree+tests+of+transmission+disequilibrium&amp;author=GR+Abecasis&amp;author=WO+Cookson&amp;author=LR+Cardon&amp;volume=8&amp;publication_year=2000&amp;pages=545-551&amp;pmid=10909856&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Price AL, Tandon A, Patterson N, et al.  Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000519.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689842/">PMC free article</a>]</span> [<a href="/pubmed/19543370" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Sensitive+detection+of+chromosomal+segments+of+distinct+ancestry+in+admixed+populations&amp;author=AL+Price&amp;author=A+Tandon&amp;author=N+Patterson&amp;volume=5&amp;publication_year=2009&amp;pages=e1000519&amp;pmid=19543370&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Devlin B, Roeder K. Genomic control for association studies. <span><span class="ref-journal">Biometrics. </span>1999;<span class="ref-vol">55</span>:997–1004.</span> [<a href="/pubmed/11315092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=Genomic+control+for+association+studies&amp;author=B+Devlin&amp;author=K+Roeder&amp;volume=55&amp;publication_year=1999&amp;pages=997-1004&amp;pmid=11315092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Willer CJ, Li Y, Abecasis GR. Metal: Fast and efficient meta-analysis of genomewide association scans. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>:2190–2191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922887/">PMC free article</a>]</span> [<a href="/pubmed/20616382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Metal:+Fast+and+efficient+meta-analysis+of+genomewide+association+scans&amp;author=CJ+Willer&amp;author=Y+Li&amp;author=GR+Abecasis&amp;volume=26&amp;publication_year=2010&amp;pages=2190-2191&amp;pmid=20616382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Torgerson DG, Boyko AR, Hernandez RD, et al.  Evolutionary processes acting on candidate cis-regulatory regions in humans inferred from patterns of polymorphism and divergence. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000592.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2714078/">PMC free article</a>]</span> [<a href="/pubmed/19662163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Evolutionary+processes+acting+on+candidate+cis-regulatory+regions+in+humans+inferred+from+patterns+of+polymorphism+and+divergence&amp;author=DG+Torgerson&amp;author=AR+Boyko&amp;author=RD+Hernandez&amp;volume=5&amp;publication_year=2009&amp;pages=e1000592&amp;pmid=19662163&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Wettergren Y, Odin E, Carlsson G, Gustavsson B. Mthfr, mtr, and mtrr polymorphisms in relation to p16ink4a hypermethylation in mucosa of patients with colorectal cancer. <span><span class="ref-journal">Mol Med. </span>2010;<span class="ref-vol">16</span>:425–432.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2935958/">PMC free article</a>]</span> [<a href="/pubmed/20549016" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Med&amp;title=Mthfr,+mtr,+and+mtrr+polymorphisms+in+relation+to+p16ink4a+hypermethylation+in+mucosa+of+patients+with+colorectal+cancer&amp;author=Y+Wettergren&amp;author=E+Odin&amp;author=G+Carlsson&amp;author=B+Gustavsson&amp;volume=16&amp;publication_year=2010&amp;pages=425-432&amp;pmid=20549016&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">de Bono JS, Twelves CJ. The oral fluorinated pyrimidines. <span><span class="ref-journal">Invest New Drugs. </span>2001;<span class="ref-vol">19</span>:41–59.</span> [<a href="/pubmed/11291832" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+New+Drugs&amp;title=The+oral+fluorinated+pyrimidines&amp;author=JS+de+Bono&amp;author=CJ+Twelves&amp;volume=19&amp;publication_year=2001&amp;pages=41-59&amp;pmid=11291832&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Johnson RC, Nelson GW, Troyer JL, et al.  Accounting for multiple comparisons in a genome-wide association study (gwas) <span><span class="ref-journal">BMC Genomics. </span>2010;<span class="ref-vol">11</span>:724.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3023815/">PMC free article</a>]</span> [<a href="/pubmed/21176216" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Genomics&amp;title=Accounting+for+multiple+comparisons+in+a+genome-wide+association+study+(gwas)&amp;author=RC+Johnson&amp;author=GW+Nelson&amp;author=JL+Troyer&amp;volume=11&amp;publication_year=2010&amp;pages=724&amp;pmid=21176216&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Huang RS, Duan S, Shukla SJ, et al.  Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. <span><span class="ref-journal">American Journal of Human Genetics. </span>2007;<span class="ref-vol">81</span>:427–437.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950832/">PMC free article</a>]</span> [<a href="/pubmed/17701890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Human+Genetics&amp;title=Identification+of+genetic+variants+contributing+to+cisplatin-induced+cytotoxicity+by+use+of+a+genomewide+approach&amp;author=RS+Huang&amp;author=S+Duan&amp;author=SJ+Shukla&amp;volume=81&amp;publication_year=2007&amp;pages=427-437&amp;pmid=17701890&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Pentheroudakis G, Twelves C. Capecitabine (xeloda): From the laboratory to the patient’s home. <span><span class="ref-journal">Clin Colorectal Cancer. </span>2002;<span class="ref-vol">2</span>:16–23.</span> [<a href="/pubmed/12453332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Colorectal+Cancer&amp;title=Capecitabine+(xeloda):+From+the+laboratory+to+the+patient’s+home&amp;author=G+Pentheroudakis&amp;author=C+Twelves&amp;volume=2&amp;publication_year=2002&amp;pages=16-23&amp;pmid=12453332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Zhang X, Diasio RB. Regulation of human dihydropyrimidine dehydrogenase: Implications in the pharmacogenetics of 5-fu-based chemotherapy. <span><span class="ref-journal">Pharmacogenomics. </span>2007;<span class="ref-vol">8</span>:257–265.</span> [<a href="/pubmed/17324113" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Regulation+of+human+dihydropyrimidine+dehydrogenase:+Implications+in+the+pharmacogenetics+of+5-fu-based+chemotherapy&amp;author=X+Zhang&amp;author=RB+Diasio&amp;volume=8&amp;publication_year=2007&amp;pages=257-265&amp;pmid=17324113&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Salgado J, Zabalegui N, Gil C, Monreal I, Rodriguez J, Garcia-Foncillas J. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer. <span><span class="ref-journal">Oncol Rep. </span>2007;<span class="ref-vol">17</span>:325–328.</span> [<a href="/pubmed/17203168" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Rep&amp;title=Polymorphisms+in+the+thymidylate+synthase+and+dihydropyrimidine+dehydrogenase+genes+predict+response+and+toxicity+to+capecitabine-raltitrexed+in+colorectal+cancer&amp;author=J+Salgado&amp;author=N+Zabalegui&amp;author=C+Gil&amp;author=I+Monreal&amp;author=J+Rodriguez&amp;volume=17&amp;publication_year=2007&amp;pages=325-328&amp;pmid=17203168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Etienne-Grimaldi MC, Francoual M, Formento JL, Milano G. Methylenetetrahydrofolate reductase (mthfr) variants and fluorouracil-based treatments in colorectal cancer. <span><span class="ref-journal">Pharmacogenomics. </span>2007;<span class="ref-vol">8</span>:1561–1566.</span> [<a href="/pubmed/18034621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Methylenetetrahydrofolate+reductase+(mthfr)+variants+and+fluorouracil-based+treatments+in+colorectal+cancer&amp;author=MC+Etienne-Grimaldi&amp;author=M+Francoual&amp;author=JL+Formento&amp;author=G+Milano&amp;volume=8&amp;publication_year=2007&amp;pages=1561-1566&amp;pmid=18034621&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Pardini B, Kumar R, Naccarati A, et al.  5-fluorouracil-based chemotherapy for colorectal cancer and mthfr/mtrr genotypes. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2010</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3141199/">PMC free article</a>]</span> [<a href="/pubmed/21204909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;title=5-fluorouracil-based+chemotherapy+for+colorectal+cancer+and+mthfr/mtrr+genotypes&amp;author=B+Pardini&amp;author=R+Kumar&amp;author=A+Naccarati&amp;publication_year=2010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Okazaki N, Ikeda S, Ohara R, et al.  The novel protein complex with smarcad1/kiaa1122 binds to the vicinity of tss. <span><span class="ref-journal">J Mol Biol. </span>2008;<span class="ref-vol">382</span>:257–265.</span> [<a href="/pubmed/18675275" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Biol&amp;title=The+novel+protein+complex+with+smarcad1/kiaa1122+binds+to+the+vicinity+of+tss&amp;author=N+Okazaki&amp;author=S+Ikeda&amp;author=R+Ohara&amp;volume=382&amp;publication_year=2008&amp;pages=257-265&amp;pmid=18675275&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Cetin E, Cengiz B, Gunduz E, et al.  Deletion mapping of chromosome 4q22–35 and identification of four frequently deleted regions in head and neck cancers. <span><span class="ref-journal">Neoplasma. </span>2008;<span class="ref-vol">55</span>:299–304.</span> [<a href="/pubmed/18505340" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasma&amp;title=Deletion+mapping+of+chromosome+4q22–35+and+identification+of+four+frequently+deleted+regions+in+head+and+neck+cancers&amp;author=E+Cetin&amp;author=B+Cengiz&amp;author=E+Gunduz&amp;volume=55&amp;publication_year=2008&amp;pages=299-304&amp;pmid=18505340&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Adra CN, Donato JL, Badovinac R, et al.  Smarcad1, a novel human helicase family-defining member associated with genetic instability: Cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases. <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">69</span>:162–173.</span> [<a href="/pubmed/11031099" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Smarcad1,+a+novel+human+helicase+family-defining+member+associated+with+genetic+instability:+Cloning,+expression,+and+mapping+to+4q22-q23,+a+band+rich+in+breakpoints+and+deletion+mutants+involved+in+several+human+diseases&amp;author=CN+Adra&amp;author=JL+Donato&amp;author=R+Badovinac&amp;volume=69&amp;publication_year=2000&amp;pages=162-173&amp;pmid=11031099&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Pander J, Wessels JA, Gelderblom H, van der Straaten T, Punt CJ, Guchelaar HJ. Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer. <span><span class="ref-journal">Ann Oncol. </span>2010</span> [<a href="/pubmed/21048041" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Pharmacogenetic+interaction+analysis+for+the+efficacy+of+systemic+treatment+in+metastatic+colorectal+cancer&amp;author=J+Pander&amp;author=JA+Wessels&amp;author=H+Gelderblom&amp;author=T+van+der+Straaten&amp;author=CJ+Punt&amp;publication_year=2010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Largillier R, Etienne-Grimaldi MC, Formento JL, et al.  Pharmacogenetics of capecitabine in advanced breast cancer patients. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:5496–5502.</span> [<a href="/pubmed/17000685" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Pharmacogenetics+of+capecitabine+in+advanced+breast+cancer+patients&amp;author=R+Largillier&amp;author=MC+Etienne-Grimaldi&amp;author=JL+Formento&amp;volume=12&amp;publication_year=2006&amp;pages=5496-5502&amp;pmid=17000685&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Altshuler DM, Gibbs RA, Peltonen L, et al.  Integrating common and rare genetic variation in diverse human populations. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">467</span>:52–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3173859/">PMC free article</a>]</span> [<a href="/pubmed/20811451" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Integrating+common+and+rare+genetic+variation+in+diverse+human+populations&amp;author=DM+Altshuler&amp;author=RA+Gibbs&amp;author=L+Peltonen&amp;volume=467&amp;publication_year=2010&amp;pages=52-8&amp;pmid=20811451&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Frazer KA, Ballinger DG, Cox DR, et al.  A second generation human haplotype map of over 3.1 million SNPs. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">449</span>:851–61.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689609/">PMC free article</a>]</span> [<a href="/pubmed/17943122" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+second+generation+human+haplotype+map+of+over+3.1+million+SNPs&amp;author=KA+Frazer&amp;author=DG+Ballinger&amp;author=DR+Cox&amp;volume=449&amp;publication_year=2007&amp;pages=851-61&amp;pmid=17943122&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">McCarthy MI, Abecasis GR, Cardon LR, et al.  Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. <span><span class="ref-journal">Nat Rev Genet. </span>2008;<span class="ref-vol">9</span>:356–369.</span> [<a href="/pubmed/18398418" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Genome-wide+association+studies+for+complex+traits:+Consensus,+uncertainty+and+challenges&amp;author=MI+McCarthy&amp;author=GR+Abecasis&amp;author=LR+Cardon&amp;volume=9&amp;publication_year=2008&amp;pages=356-369&amp;pmid=18398418&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3413892&amp;issue-id=212836&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140598789727520title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Materials and Methods</a></li><li><a href="#S11title">Results</a></li><li><a href="#S18title">Discussion</a></li><li><a href="#S19title">Acknowledgments</a></li><li><a href="#idm140598786807424title">Footnotes</a></li><li><a href="#idm140598786806432title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3413892/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3413892/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3413892/pdf/nihms339178.pdf">PDF (1.7M)</a></li> | <li><a href="#" data-citationid="PMC3413892" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413892%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413892%2F&amp;text=Identification%20of%20Novel%20Germline%20Polymorphisms%20Governing%20Capecitabine%20Sensitivity" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413892%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22864933" data-aiid="3413892" data-aid="3413892" data-iid="212836" data-domainid="319" data-domain="nihpa" data-accid="PMC3413892" data-md5="108c0441fa1a43032518cc72ae008f33"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T09:20:42-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE890370DD54BB110000000000070003&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413892%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3413892/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>